Investor Sentiment Analysis

Today is Monday, June 12, 2023.

New to this newsletter? Sign up here.

Investor Sentiment Analysis

Early Bird is back and has a new tool to help investors gauge the current state of the market. Introducing the Early Bird Index.

  • A comprehensive measurement to gauge the prevailing sentiment and overall outlook of investors in the market.

  • On a scale of 0 to 100. The higher the number, the more optimistic investors should be about the market. The lower the number, the more pessimistic investors should be.

  • Updated daily and 100% FREE.

Check out the new Early Bird Index. Questions or comments about the Early Bird Index? Contact [email protected].

Notables

Notable Earnings Today: Oracle (NYSE: ORCL), ECARX Holdings (Nasdaq: ECX).

Notable IPOs Today: Stellar Bancorp, Inc. (NYSE: STEL), Ares Acquisition Corporation II (NYSE: AACT), Fidelity Disruptive Finance ETF (Nasdaq: FDFF), Fidelity Disruptive Medicine ETF (Nasdaq: FMED), Fidelity Disruptive Technology ETF (Nasdaq: FDTX), Fidelity Disruptive Communications ETF (Nasdaq: FDCF), Fidelity Disruptive Automation ETF (Nasdaq: FBOT), Indivior PLC Ordinary Shares (Nasdaq: INDV), EVe Mobility Acquisition Corp (NYSE American: EVE).

Notable Equity Crowdfunding Campaigns Ending Today: BuyAlerts (Republic).

Notable Economic Events Today: Federal Budget Balance (2:00 p.m. ET).

Illumina CEO Exits Following Investor Clash

Photo by National Cancer Institute / Unsplash

Amid activist investor pressure, the CEO of the biotechnology company Illumina (NASDAQ: ILMN) suddenly announced that he is stepping down on Sunday.

Details: Francis deSouza resigned from the CEO role on Sunday, but will stay on in an advisory capacity until July 31. Charles Dadswell, senior vice president, is now interim CEO. A search is underway for a permanent successor.

Quote: “We have made great progress together, but I believe we are still at the very beginning of the impact Illumina will have on human health by unlocking the power of the genome.” - former Illumina CEO Francis deSouza.

Background: Illumina has been in a proxy fight with activist investor Carl Icahn, who previously tried to replace the CEO. Last month, Icahn convinced enough shareholders to get rid of Chairman John Thompson.

Stock Price: Shares of Illumina are about even so far in 2023.

Final Thoughts: The biotech space can be tough for investors to predict. Hopefully, with a leadership change, Illumina can someday grow.

Polygon Speaks Out

The price of Polygon ticked up 2% on Sunday, higher than most other cryptocurrencies, due in part to a strong social media post on Saturday.

Details: Polygon Labs wrote on social media late Saturday that it is proud of its history and it is “grateful for all the thoughtful work being done on all aspects of this technology around the globe, including by regulators & policymakers.”

Background: The comments come days after regulators have been cracking down on Polygon and other cryptos.

Price: In the past week, Polygon lost nearly 30% of its value.

Final Thoughts: Crypto investments are considered volatile, especially in light of the recent regulatory actions.

Stock Options Genius Reveals Top Pick BEFORE He Enters the Trade (Sponsored)

Veteran trader and options pro Jeff Bishop has released a brand new report with his #1 real-money trade idea, and it’s temporarily available completely free. This detailed report outlines the stock, options contract, Jeff’s target entry, profit target & stop loss, and he has shared all the details before entering the trade himself.  Get access to the full report at no cost while it’s still available.Sign Up Now!

Trends to Watch

Sell, Sell, Sell: Companies, Big Investors Sell Shares at Fastest Rate in Years (The Wall Street Journal)

Thank you for reading!

Forward to a friend and tell them to sign up here.

Want more investing tips? Listen to the podcast.

Show Your Support: Buy Me a Coffee.

Questions or comments? Hit reply to reach out.